370 related articles for article (PubMed ID: 14529398)
21. Roles of cyclooxygenase (COX)-1 and COX-2 in prostanoid production by human endothelial cells: selective up-regulation of prostacyclin synthesis by COX-2.
Caughey GE; Cleland LG; Penglis PS; Gamble JR; James MJ
J Immunol; 2001 Sep; 167(5):2831-8. PubMed ID: 11509629
[TBL] [Abstract][Full Text] [Related]
22. Limited anti-inflammatory efficacy of cyclo-oxygenase-2 inhibition in carrageenan-airpouch inflammation.
Wallace JL; Chapman K; McKnight W
Br J Pharmacol; 1999 Mar; 126(5):1200-4. PubMed ID: 10205009
[TBL] [Abstract][Full Text] [Related]
23. [Biological functions of cyclooxygenase 2: control of its expression and activity].
Jacquemin C
J Soc Biol; 2000; 194(3-4):189-93. PubMed ID: 11324321
[TBL] [Abstract][Full Text] [Related]
24. In vitro and in vivo pharmacological evidence of selective cyclooxygenase-2 inhibition by nimesulide: an overview.
Famaey JP
Inflamm Res; 1997 Nov; 46(11):437-46. PubMed ID: 9427063
[TBL] [Abstract][Full Text] [Related]
25. The cyclooxygenase isoforms: structural insights into the conversion of arachidonic acid to prostaglandins.
Garavito RM; DeWitt DL
Biochim Biophys Acta; 1999 Nov; 1441(2-3):278-87. PubMed ID: 10570255
[TBL] [Abstract][Full Text] [Related]
26. Cyclooxygenase-2 and gastrointestinal cancer.
Mann JR; DuBois RN
Cancer J; 2004; 10(3):145-52. PubMed ID: 15285921
[TBL] [Abstract][Full Text] [Related]
27. Role of cyclooxygenase-2 in the angiogenesis of colorectal cancer.
Rao M; Yang W; Seifalian AM; Winslet MC
Int J Colorectal Dis; 2004 Jan; 19(1):1-11. PubMed ID: 12783255
[TBL] [Abstract][Full Text] [Related]
28. [Current status of study on selective cyclooxygenase-2 inhibitors and evaluation of its application].
He W; Liu CF; Huang CQ
Di Yi Jun Yi Da Xue Xue Bao; 2002 Feb; 22(2):184-6. PubMed ID: 12390825
[TBL] [Abstract][Full Text] [Related]
29. [Clinical application of cyclooxygenase-2 inhibitors].
Dzielska-Olczak M; Olczak S
Pol Merkur Lekarski; 2001 Jun; 10(60):480-2. PubMed ID: 11503270
[TBL] [Abstract][Full Text] [Related]
30. Cardiovascular pharmacology of nonselective nonsteroidal anti-inflammatory drugs and coxibs: clinical considerations.
FitzGerald GA
Am J Cardiol; 2002 Mar; 89(6A):26D-32D. PubMed ID: 11909558
[TBL] [Abstract][Full Text] [Related]
31. Classic NSAID and selective cyclooxygenase (COX)-1 and COX-2 inhibitors in healing of chronic gastric ulcers.
Brzozowski T; Konturek PC; Konturek SJ; Sliwowski Z; Pajdo R; Drozdowicz D; Ptak A; Hahn EG
Microsc Res Tech; 2001 Jun; 53(5):343-53. PubMed ID: 11376495
[TBL] [Abstract][Full Text] [Related]
32. Potential adverse effects of cyclooxygenase-2 inhibition: evidence from animal models of inflammation.
Colville-Nash PR; Gilroy DW
BioDrugs; 2001; 15(1):1-9. PubMed ID: 11437671
[TBL] [Abstract][Full Text] [Related]
33. The mechanism of action of aspirin.
Vane JR; Botting RM
Thromb Res; 2003 Jun; 110(5-6):255-8. PubMed ID: 14592543
[TBL] [Abstract][Full Text] [Related]
34. Prevention of thrombosis and vascular inflammation: benefits and limitations of selective or combined COX-1, COX-2 and 5-LOX inhibitors.
de Gaetano G; Donati MB; Cerletti C
Trends Pharmacol Sci; 2003 May; 24(5):245-52. PubMed ID: 12767724
[TBL] [Abstract][Full Text] [Related]
35. [Specific cyclo-oxygenase-2 inhibitors in cardiovascular pathology].
Monsuez JJ
Arch Mal Coeur Vaiss; 2004 Jun; 97(6):632-40. PubMed ID: 15283037
[TBL] [Abstract][Full Text] [Related]
36. Unorthodox routes to prostanoid formation: new twists in cyclooxygenase-initiated pathways.
Serhan CN; Oliw E
J Clin Invest; 2001 Jun; 107(12):1481-9. PubMed ID: 11413151
[No Abstract] [Full Text] [Related]
37. COX-2, NSAIDs and human neoplasia. Part I: Colorectal neoplasms.
Nasir A; Fernandez PM; Chughtai OR; Kaiser HE
In Vivo; 2002; 16(6):501-9. PubMed ID: 12494894
[TBL] [Abstract][Full Text] [Related]
38. [Current topics in the regulation of prostanoids-1. Inducible cyclooxygenase COX-2 and selective blockers].
Ohara M; Sawa T
Masui; 1998 Nov; 47(11):1325-32. PubMed ID: 9852696
[TBL] [Abstract][Full Text] [Related]
39. Cyclooxygenase enzymes: regulation and function.
Fitzpatrick FA
Curr Pharm Des; 2004; 10(6):577-88. PubMed ID: 14965321
[TBL] [Abstract][Full Text] [Related]
40. Cyclooxygenase 2 inhibitors: discovery, selectivity and the future.
Marnett LJ; Kalgutkar AS
Trends Pharmacol Sci; 1999 Nov; 20(11):465-9. PubMed ID: 10542447
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]